Chemfab Alkalis Ltd
Incorproated in 2009, Chemfab
Alkalis Ltd manufactures basic
inorganic chemicals and PVCO
pipes[1]
- Market Cap ₹ 1,134 Cr.
- Current Price ₹ 789
- High / Low ₹ 1,230 / 500
- Stock P/E 74.5
- Book Value ₹ 284
- Dividend Yield 0.16 %
- ROCE 5.91 %
- ROE 3.80 %
- Face Value ₹ 10.0
Pros
Cons
- Promoter holding has decreased over last quarter: -0.39%
- The company has delivered a poor sales growth of 9.51% over past five years.
- Company has a low return on equity of 10.2% over last 3 years.
- Dividend payout has been low at 6.80% of profits over last 3 years
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Commodities Chemicals Chemicals & Petrochemicals Commodity Chemicals
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
21 | 30 | 25 | 140 | 180 | 193 | 205 | 181 | 272 | 331 | 327 | 322 | |
23 | 29 | 18 | 108 | 128 | 133 | 149 | 157 | 215 | 219 | 269 | 269 | |
Operating Profit | -3 | 0 | 7 | 32 | 52 | 61 | 56 | 24 | 57 | 112 | 58 | 53 |
OPM % | -13% | 1% | 27% | 23% | 29% | 31% | 27% | 13% | 21% | 34% | 18% | 17% |
3 | 3 | 0 | 2 | 4 | -15 | -0 | 1 | 6 | 2 | 8 | 6 | |
Interest | 8 | 7 | 3 | 5 | 4 | 2 | 4 | 3 | 1 | 1 | 1 | 5 |
Depreciation | 3 | 4 | 4 | 13 | 12 | 15 | 25 | 20 | 22 | 23 | 22 | 32 |
Profit before tax | -10 | -7 | 0 | 16 | 40 | 28 | 27 | 2 | 39 | 91 | 43 | 22 |
Tax % | 0% | 0% | 0% | 6% | 36% | 41% | 5% | 479% | 26% | 27% | 30% | 30% |
-10 | -7 | 0 | 16 | 25 | 17 | 26 | -8 | 29 | 66 | 30 | 15 | |
EPS in Rs | 18.42 | 12.07 | 18.36 | -5.72 | 20.40 | 46.69 | 21.08 | 10.60 | ||||
Dividend Payout % | 0% | 0% | 0% | 11% | 7% | 10% | 7% | 0% | 6% | 3% | 6% | 12% |
Compounded Sales Growth | |
---|---|
10 Years: | 27% |
5 Years: | 10% |
3 Years: | 6% |
TTM: | -2% |
Compounded Profit Growth | |
---|---|
10 Years: | 15% |
5 Years: | -11% |
3 Years: | -19% |
TTM: | -49% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | 42% |
3 Years: | 68% |
1 Year: | 46% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | 8% |
3 Years: | 10% |
Last Year: | 4% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 5 | 5 | 7 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 |
Reserves | -17 | -24 | -17 | 201 | 222 | 237 | 262 | 254 | 284 | 349 | 379 | 393 |
76 | 82 | 66 | 16 | 23 | 34 | 43 | 31 | 9 | 2 | 20 | 84 | |
10 | 10 | 14 | 44 | 39 | 36 | 30 | 36 | 45 | 48 | 85 | 54 | |
Total Liabilities | 75 | 73 | 70 | 275 | 298 | 321 | 348 | 335 | 352 | 413 | 498 | 546 |
64 | 61 | 57 | 164 | 173 | 194 | 195 | 202 | 194 | 191 | 181 | 249 | |
CWIP | 0 | 0 | 1 | 11 | 2 | 10 | 35 | 3 | 7 | 14 | 57 | 12 |
Investments | 0 | 0 | 0 | 0 | 0 | 0 | 8 | 31 | 42 | 110 | 110 | 164 |
10 | 12 | 12 | 99 | 124 | 117 | 110 | 98 | 109 | 98 | 150 | 121 | |
Total Assets | 75 | 73 | 70 | 275 | 298 | 321 | 348 | 335 | 352 | 413 | 498 | 546 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
-0 | -1 | 38 | 44 | 41 | 54 | 46 | 55 | 97 | 52 | 61 | ||
-1 | -1 | -9 | -30 | -47 | -58 | -7 | -21 | -52 | -130 | -107 | ||
1 | 0 | -30 | -13 | 6 | 3 | -16 | -25 | -9 | 16 | 59 | ||
Net Cash Flow | -0 | -2 | -1 | 1 | 0 | -1 | 23 | 9 | 36 | -62 | 13 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 49 | 42 | 9 | 22 | 35 | 31 | 17 | 31 | 29 | 24 | 24 | 23 |
Inventory Days | 341 | 320 | 203 | 152 | 84 | 79 | 54 | 89 | 58 | 99 | ||
Days Payable | 320 | 64 | 546 | 225 | 164 | 156 | 92 | 145 | 101 | 133 | ||
Cash Conversion Cycle | 70 | 298 | -334 | 22 | 35 | -43 | -63 | -47 | -9 | -32 | -20 | -12 |
Working Capital Days | -177 | -166 | -329 | -24 | -3 | 10 | 23 | 30 | 15 | 8 | -26 | 22 |
ROCE % | -4% | -0% | 6% | 15% | 17% | 18% | 11% | 2% | 13% | 28% | 11% | 6% |
Documents
Announcements
-
Compliances-Reg.24(A)-Annual Secretarial Compliance
1d - Annual Secretarial Compliance Report for FY 2024-25 submitted as per SEBI regulations.
-
Announcement under Regulation 30 (LODR)-Change in Directorate
1d - Appointment of Mr. Satish Narain Jajoo as Additional Independent Director for 5 years from May 30, 2025.
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
17 May - Dear Sir/Madam, Please find the attached Copy of Newspaper publication of Audited financial results for the quarter and year ended 31.03.2025
-
Announcement under Regulation 30 (LODR)-Investor Presentation
15 May - Dear Sir/madam, Please find the attached investor presentation for the quarter and year ended on 31st March, 2025
- Corporate Action-Board approves Dividend 14 May
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
Concalls
-
May 2025TranscriptNotesPPT
Business Overview:[1][2]
CAL is an ISO 14001 and OHSAS 18001 certified manufacturer of choloro alkali products. It uses Membrane Technology for Chloralkali production. Company also produces chlorine, hydrogen, sodium hypo chlorite, and hydrochloric acid as by-products from manufacture of caustic soda